Meddenovo Drug Design

Lyon, France

Meddenovo Drug Design develops AI-supported solutions to design cyclic peptide therapeutics.

Jan 2025

Seed

Artificial Intelligence (AI)Biopharma Biotechnology Life Science Pharmaceutical

Top Investors

ACT Venture Partners Invest 101

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Meddenovo Drug Design

Who are Meddenovo Drug Design's investors?

Meddenovo Drug Design's investors include ACT Venture Partners, Invest 101.

Where is Meddenovo Drug Design headquartered?

Meddenovo Drug Design is headquartered in Lyon, France.

What does Meddenovo Drug Design do?

Meddenovo Drug Design develops AI-supported solutions to design cyclic peptide therapeutics.

What stage is Meddenovo Drug Design at?

Meddenovo Drug Design is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2025.

MLA

"Meddenovo Drug Design — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/meddenovo-drug-design. Accessed July 2, 2026.

APA

VCBacked. (2025). Meddenovo Drug Design — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/meddenovo-drug-design

Wikipedia (cite web)

{{cite web |title=Meddenovo Drug Design — Funding & Investors |url=https://www.vcbacked.co/company/meddenovo-drug-design |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2025.